← brief for 2026-09-16 · People & money

Evaluation and Management of Anemia in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2026 Clinical Practice Guideline

Paper A Peer reviewed Meta-analysis or large trial

Key takeaways

Kidney disease experts updated their 2026 guidelines on treating anemia in chronic kidney disease, based on the best available evidence from large studies and trials.

Who did this work

S. Susan Hedayati (The University of Texas Southwestern Medical Center) · Jodie L. Babitt (Massachusetts General Hospital) · Jeffrey S. Berns (Hospital of the University of Pennsylvania) · Biykem Bozkurt (Baylor College of Medicine) · Rebecca Cheung (University of Washington) · Emmanuel Effa (Kidney Research UK) · Emmanuel E. Effa (University of Cross River State) · Michele F. Eisenga (University Medical Center Groningen) · Steven Fishbane (Hofstra University) · Yelena Ginzburg (Mount Sinai Hospital) · Volker H. Haase (VA Tennessee Valley Healthcare System) · Siah Kim (Children's Hospital at Westmead)

Source

Paper · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-09-14
https://doi.org/10.7326/annals-26-02326